Meanwhile, epigenetically silenced expression of DACH1 in several kinds of cancers could be restored by HDACs inhibitors and resulted in reduced proliferation [19, 20], thus providing a potential approach by the demethylase treatment to recover the expression of DACH1 in HCC patients. Here, DACH1 is linked to hepatocellular carcinoma.